ERBB2 and breast carcinoma: In breast cancer, overactivation Sp1 caused by HER2 induced the accumulation of HDAC1 at MIR146A gene promoter, which decreased miR146A expression and consequently increased its oncogenic targets, interleukin‐1 receptor‐associated kinase 1 and the chemokine receptor CXCR4.24